Alta Charo

CRISPR baby moratorium grows likely with rising tide of support including from biotech

CRISPR-gene-edit-vs-mutation-1

Trying to make a CRISPR baby any time soon would be a really bad idea. How bad? Last December 3rd I penned a piece for STAT News arguing for a moratorium on the heritable use of CRISPR in humans. This potential future, radical application of “gene editing” is now often colloquially referred to as “CRISPR …

CRISPR baby moratorium grows likely with rising tide of support including from biotech Read More »

National Academies panel leaves door a crack open to future human genetic modification

Early-human-embryos

A National Academies panel on human genome editing chaired by Alta Charo and Richard Hynes released its report today. While it covered both somatic and germline (heritable) human genetic modification, the latter topic is far more contentious. You can see the National Academies summary of their report here. You can read the full report here. …

National Academies panel leaves door a crack open to future human genetic modification Read More »

New #CRISPR updates: Editas to go public, patent issues, dragons & more

CRISPR-dragon

A lot has been going on in the CRISPR world. Here are some key CRISPR updates. Editas has filed the paperwork on the road to going public as a company. Such an IPO, should it come to fruition, could raise billions of dollars. Will the other CRISPR companies like Caribou and CRISPR¬†Therapeutics follow suit? Simplistically, …

New #CRISPR updates: Editas to go public, patent issues, dragons & more Read More »